Logo image
Comparing the Infectious and Neoplastic Adverse Event Profiles of Ocrelizumab and Cladribine Using the FDA Adverse Event Reporting Database (P9-6.009)
Journal article   Peer reviewed

Comparing the Infectious and Neoplastic Adverse Event Profiles of Ocrelizumab and Cladribine Using the FDA Adverse Event Reporting Database (P9-6.009)

Nasrin Rahimian, Olaf Stuve and Afsaneh Shirani
Neurology, Vol.102(7_supplement_1)
04/09/2024

Metrics

1 Record Views

Details

Logo image